Keywords: Alzheimer's Disease, Alzheimer's Disease, Taurine treatment
Motivation: The current strategies of targeting patients with Alzheimer’s Disease (AD) suggest that preventative therapies might be more efficient than repairing extensive pathology in progressed AD.
Goal(s): We aim to see if taurine can prevent or slow down the progression of AD pathology and its physiologic and metabolic effects in the 5xFAD mouse model.
Approach: We have used post-mortem measures of markers of neuroinflammation, neuroanatomy and AD pathology markers, along with longitudinal in-vivo imaging of brain chemistry and anatomy.
Results: We have seen taurine acting as a protective agent, as it improved the neurochemical profiles of 5xFAD mice in different regions of the brain.
Impact: Taurine supplementation led to an increase in brain taurine levels. It protected decreased CBF and increased iron deposition as well as preventing decreases in NAA and other metabolites associated with progression of AD pathology - further study is warranted.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords